PL4041128T3 - Systemy i urządzenia do leczenia łagodnego przerostu gruczołu krokowego i związanych z nim objawów dolnych dróg moczowych - Google Patents

Systemy i urządzenia do leczenia łagodnego przerostu gruczołu krokowego i związanych z nim objawów dolnych dróg moczowych

Info

Publication number
PL4041128T3
PL4041128T3 PL20875066.1T PL20875066T PL4041128T3 PL 4041128 T3 PL4041128 T3 PL 4041128T3 PL 20875066 T PL20875066 T PL 20875066T PL 4041128 T3 PL4041128 T3 PL 4041128T3
Authority
PL
Poland
Prior art keywords
treatment
devices
delivery systems
urinary tract
benign prostatic
Prior art date
Application number
PL20875066.1T
Other languages
English (en)
Inventor
Kenneth Chih-Ping Chang
Gary Daniel Zaretzka
Jimmy Jen
Kondapavulur T. Venkateswara-Rao
Original Assignee
Prodeon Medical Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Prodeon Medical Corporation filed Critical Prodeon Medical Corporation
Publication of PL4041128T3 publication Critical patent/PL4041128T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B1/00—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor
    • A61B1/307—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor for the urinary organs, e.g. urethroscopes, cystoscopes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheets or tubes, e.g. perforated by laser cuts or etched holes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/95—Instruments specially adapted for placement or removal of stents or stent-grafts
    • A61F2/9517—Instruments specially adapted for placement or removal of stents or stent-grafts handle assemblies therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/95—Instruments specially adapted for placement or removal of stents or stent-grafts
    • A61F2/962—Instruments specially adapted for placement or removal of stents or stent-grafts having an outer sleeve
    • A61F2/966—Instruments specially adapted for placement or removal of stents or stent-grafts having an outer sleeve with relative longitudinal movement between outer sleeve and prosthesis, e.g. using a push rod
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2002/047—Urethrae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0058—Additional features; Implant or prostheses properties not otherwise provided for
    • A61F2250/0067—Means for introducing or releasing pharmaceutical products into the body
    • A61F2250/0068—Means for introducing or releasing pharmaceutical products into the body the pharmaceutical product being in a reservoir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0058—Additional features; Implant or prostheses properties not otherwise provided for
    • A61F2250/0096—Markers and sensors for detecting a position or changes of a position of an implant, e.g. RF sensors, ultrasound markers
    • A61F2250/0097—Visible markings, e.g. indicia

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Transplantation (AREA)
  • Cardiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Vascular Medicine (AREA)
  • Surgery (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Molecular Biology (AREA)
  • Medical Informatics (AREA)
  • Radiology & Medical Imaging (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Urology & Nephrology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • Surgical Instruments (AREA)
  • Prostheses (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
PL20875066.1T 2019-10-09 2020-10-09 Systemy i urządzenia do leczenia łagodnego przerostu gruczołu krokowego i związanych z nim objawów dolnych dróg moczowych PL4041128T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962912759P 2019-10-09 2019-10-09
PCT/US2020/055067 WO2021072258A1 (en) 2019-10-09 2020-10-09 Delivery systems and devices for the treatment of benign prostatic hyperplasia and related lower urinary tract symptoms

Publications (1)

Publication Number Publication Date
PL4041128T3 true PL4041128T3 (pl) 2025-12-08

Family

ID=75436806

Family Applications (1)

Application Number Title Priority Date Filing Date
PL20875066.1T PL4041128T3 (pl) 2019-10-09 2020-10-09 Systemy i urządzenia do leczenia łagodnego przerostu gruczołu krokowego i związanych z nim objawów dolnych dróg moczowych

Country Status (14)

Country Link
EP (1) EP4041128B1 (pl)
JP (1) JP7717690B2 (pl)
KR (1) KR102935005B1 (pl)
CN (1) CN114641259B (pl)
AU (1) AU2020361620B2 (pl)
BR (1) BR112022005556A2 (pl)
CA (1) CA3156272A1 (pl)
DK (1) DK4041128T3 (pl)
ES (1) ES3039323T3 (pl)
FI (1) FI4041128T3 (pl)
MX (1) MX2022004337A (pl)
PL (1) PL4041128T3 (pl)
TW (2) TWI901353B (pl)
WO (1) WO2021072258A1 (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11812930B2 (en) * 2019-12-03 2023-11-14 Prodeon Medical Corporation Devices for the treatment of benign prostatic hyperplasia and related lower urinary tract symptoms
DE102021133393A1 (de) * 2021-12-15 2023-06-15 Olympus Winter & Ibe Gmbh Implantat
JP2025188010A (ja) * 2024-06-13 2025-12-25 メディ－テイト リミテッド ステントデバイス

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6629981B2 (en) * 2000-07-06 2003-10-07 Endocare, Inc. Stent delivery system
US7105016B2 (en) * 2002-04-23 2006-09-12 Medtronic Vascular, Inc. Integrated mechanical handle with quick slide mechanism
US6849084B2 (en) * 2002-12-31 2005-02-01 Intek Technology L.L.C. Stent delivery system
US20070156225A1 (en) * 2003-12-23 2007-07-05 Xtent, Inc. Automated control mechanisms and methods for custom length stent apparatus
US7326236B2 (en) * 2003-12-23 2008-02-05 Xtent, Inc. Devices and methods for controlling and indicating the length of an interventional element
US20090204005A1 (en) * 2008-02-07 2009-08-13 Broncus Technologies, Inc. Puncture resistant catheter for sensing vessels and for creating passages in tissue
JP5284165B2 (ja) 2009-03-31 2013-09-11 テルモ株式会社 生体器官病変部改善用器具
EP2627290A1 (en) * 2010-10-14 2013-08-21 Boston Scientific Scimed, Inc. Outer tube for stent repositioning and deployment
US20120191174A1 (en) * 2010-11-16 2012-07-26 Trivascular, Inc. Advanced endovascular graft and delivery system
CN105263442B (zh) * 2013-02-04 2019-02-15 托尔福公司 用于人工心脏瓣膜装置的液压输送系统及相关方法
US9956103B2 (en) 2013-03-11 2018-05-01 DePuy Synthes Products, Inc. Stent delivery system and method
HK1225258B (en) * 2013-08-08 2017-09-08 Global Bio Therapeutics, Inc. Clamping device for minimally invasive surgery
WO2015167997A1 (en) * 2014-04-30 2015-11-05 Stryker Corporation Implant delivery system and method of use
US10159586B2 (en) 2015-06-29 2018-12-25 480 Biomedical Inc. Scaffold loading and delivery systems
WO2017008917A1 (en) * 2015-07-13 2017-01-19 Cti Vascular Ag Mechanically actuated and functionally integratable catheter system for treating vascular and non-vascular diseases
EP3175821A1 (en) * 2015-12-02 2017-06-07 Mitricares Delivery apparatus for self-expanding medical device
US10779940B2 (en) * 2015-09-03 2020-09-22 Boston Scientific Scimed, Inc. Medical device handle
JP2017051502A (ja) * 2015-09-10 2017-03-16 テルモ株式会社 自己拡張型ステントデリバリーシステム
AU2017254659B2 (en) * 2016-04-21 2022-10-06 Zenflow, Inc. Systems and methods for implants and deployment devices
CN106466194B (zh) * 2016-08-30 2019-10-29 上海复堂生物科技有限公司 内镜穿刺针
CN107157621B (zh) 2016-09-23 2024-07-30 杭州启明医疗器械股份有限公司 一种可回收及重复定位介入器械的输送系统
CN110381897A (zh) * 2016-12-29 2019-10-25 波士顿科学国际有限公司 用于将支架装载至递送装置中的方法
KR102487146B1 (ko) * 2017-05-05 2023-01-12 프로데온 메디칼 코포레이션 양성 전립선 비대증(bph) 및 하부 요로 증상(luts)을 치료하기 위한 임플란트
US10856982B2 (en) * 2017-09-19 2020-12-08 St. Jude Medical, Cardiology Division, Inc. Transapical mitral valve delivery system
US10932931B2 (en) 2018-03-13 2021-03-02 Medtronic Vascular, Inc. Medical device delivery system including a support member

Also Published As

Publication number Publication date
AU2020361620A1 (en) 2022-04-14
TWI859345B (zh) 2024-10-21
AU2020361620B2 (en) 2025-08-21
TW202130319A (zh) 2021-08-16
TWI901353B (zh) 2025-10-11
FI4041128T3 (fi) 2025-09-18
EP4041128A4 (en) 2022-11-23
KR102935005B1 (ko) 2026-03-09
KR20220079927A (ko) 2022-06-14
JP2022551491A (ja) 2022-12-09
CN114641259A (zh) 2022-06-17
EP4041128B1 (en) 2025-07-30
JP7717690B2 (ja) 2025-08-04
CN114641259B (zh) 2026-03-31
ES3039323T3 (en) 2025-10-21
WO2021072258A1 (en) 2021-04-15
MX2022004337A (es) 2022-07-19
CA3156272A1 (en) 2021-04-15
DK4041128T3 (da) 2025-09-22
BR112022005556A2 (pt) 2022-06-21
EP4041128A1 (en) 2022-08-17
TW202504564A (zh) 2025-02-01

Similar Documents

Publication Publication Date Title
EP4051081A4 (en) DEVICES FOR THE TREATMENT OF BENIGN PROSTATE HYPERPLASIA AND ASSOCIATED LOWER URINARY TRACT SYMPTOMS
EP3618914A4 (en) IMPLANTABLE DEVICES AND METHODS FOR TREATMENT OF BENIGNER PROSTATE HYPERPLASIA (BPH) AND RELATED LOWER URINE TRAIN SYMPTOMS (LUTS)
PL4041128T3 (pl) Systemy i urządzenia do leczenia łagodnego przerostu gruczołu krokowego i związanych z nim objawów dolnych dróg moczowych
SG11202105158VA (en) Combination therapy including a krasg12c inhibitor and one or more additional pharmaceutically active agents for the treatment of cancers
MX2019006867A (es) Tratamiento de una enfermedad del tracto gastrointestinal con un inhibidor de integrina.
GB2458403A (en) Corticosteroid compositions
EP2440210A4 (en) METHOD FOR THE TREATMENT OF STOMACH DARM DISEASES
MX2019006821A (es) Tratamiento de una enfermedad del tracto gastrointestinal con un inhibidor de cinasa de janus (jak) y dispositivos.
SI3324994T1 (sl) NX-1207 za uporabo v postopkih za zmanjšanje potrebe po operaciji pri pacientih, ki trpijo za benigno hiperplazijo prostate
PL3068414T3 (pl) Kompozycje i sposoby użyteczne w leczeniu objawów z dolnego odcinka układu moczowego, łagodnego przerostu prostaty, zaburzeń erekcji
WO2008011093A3 (en) Implantable devices containing nuclear receptor ligands for the treatment of vascular and related disorders
SG166106A1 (en) Pde inhibitors and combinations thereof for the treatment of urological disorders
IL263917A (en) Pthalazine derivatives as parp1, parp2 and/or tubulin suppressors for use in cancer therapy
EP3735286A4 (en) DEVICES FOR DELIVERY OF THERAPEUTIC AGENTS WITH INTEGRATED PAIN RELIEF, AND THEIR METHODS FOR USE
PT3911347T (pt) Composição para a sua utilização no tratamento da incontinência urinária na mulher
IL282924A (en) Devices for drug delivery and systems for local drug delivery to the upper urinary tract
EP3648741A4 (en) TREATMENT OF HYPERPLASTIC TISSUE GROWTH INCLUDING BENEFIT PROSTATE HYPERPLASIA (BPH) BY DIRECT INJECTION OF ANTINEOPLASTIC AGENT
BE1016292A3 (nl) Verbinding en gebruik bij behandeling.
EP3731930C0 (en) MULTIKINASE INHIBITORS AND THEIR USES IN PROSTATE HYPERPLASIA AND URINARY TRACT DISEASES
WO2012075472A3 (en) Chemical entities and therapeutic uses thereof
IL204694A0 (en) Composition and method for treatment or prevention of benign prostatic hyperplasia and lower urinary tract symptoms
MX2019007972A (es) Inhibidores de il-8 para usarse en el tratamiento de algunos trastornos urologicos.
MX2019011118A (es) Uso de oleorresina de copaifera en patologias de la prostata.
Madersbacher Re: Efficacy and safety of tadalafil 5mg once daily in the treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia in men aged≥ 75 years: Integrated analyses of pooled data from multinational, randomized, placebo-controlled clinical studies
Fujimura Editorial comment to" Evaluation and validation of the core lower urinary tract symptom score as an outcome assessment tool for the treatment of benign prostatic hyperplasia: effects of the α1-adrenoreceptor antagonist silodosin"